“…The radiolabeling of blood constituents has a great importance in nuclear medicine (Saha, 2004). Some authors have suggested that drugs could alter the radiolabeling of blood constituents (Moreno et al, 2002;Abreu et al, 2006;Silva et al, 2006), as well as, promote morphological alterations on the erythrocyte membrane Oliveira et al, 2002;Santos-Filho et al, 2004;Moreno et al, 2004). Other studies report that some natural products could not interfere on the radiolabeling of blood constituents Fernandez et al, 2005) and could not modify the morphology of the red blood cells (Fernandez et al, 2005).…”